KalVista Pharmaceuticals, Inc. (KALV) Net Income by Year
KalVista Pharmaceuticals, Inc. reported a net loss of $183.4M in fiscal year 2025. This represents a decrease of 44.9% from the prior fiscal year. The table below carries 12 fiscal years, from 2013 to 2025, and the quarters KalVista Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
KALV Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
KALV Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More KalVista Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was KalVista Pharmaceuticals, Inc.'s net income in fiscal year 2025?
KalVista Pharmaceuticals, Inc. reported a net loss of $183.4M in fiscal year 2025.
How fast is KalVista Pharmaceuticals, Inc.'s net income growing?
KalVista Pharmaceuticals, Inc. (KALV) net income fell by 44.9% year over year, from -$126.6M to -$183.4M in fiscal year 2025.
How has KalVista Pharmaceuticals, Inc.'s net income changed over the years?
Across the 12 fiscal years this page covers, KalVista Pharmaceuticals, Inc. (KALV) net income went from -$5.7M in fiscal year 2013 to -$183.4M in fiscal year 2025.
What was KalVista Pharmaceuticals, Inc.'s net income in the most recent quarter?
KalVista Pharmaceuticals, Inc. (KALV) reported -$23.5M in net income in Q4 2026. This represents an increase of 54.7% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what KalVista Pharmaceuticals, Inc. (KALV) reported on that line in every period on record.